SCYNEXIS (SCYX) Revenue & Revenue Breakdown
SCYNEXIS Revenue Highlights
Latest Revenue (Y)
$140.14M
Latest Revenue (Q)
$736.00K
Main Segment (Y)
License and Service
SCYNEXIS Revenue by Period
SCYNEXIS Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $140.14M | 2652.72% |
2022-12-31 | $5.09M | -61.32% |
2021-12-31 | $13.16M | 100.00% |
2020-12-31 | - | -100.00% |
2019-12-31 | $121.00K | -52.92% |
2018-12-31 | $257.00K | - |
2017-12-31 | $257.00K | - |
2016-12-31 | $257.00K | - |
2015-12-31 | $257.00K | -79.54% |
2014-12-31 | $1.26M | -92.55% |
2013-12-31 | $16.86M | 0.12% |
2012-12-31 | $16.84M | - |
SCYNEXIS Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $736.00K | -46.39% |
2024-03-31 | $1.37M | -76.32% |
2023-12-31 | $5.80M | 229.19% |
2023-09-30 | $1.76M | -98.66% |
2023-06-30 | $131.45M | 11533.10% |
2023-03-31 | $1.13M | -25.85% |
2022-12-31 | $1.52M | -2.12% |
2022-09-30 | $1.56M | 17.69% |
2022-06-30 | $1.32M | 92.58% |
2022-03-31 | $687.00K | 15.08% |
2021-12-31 | $597.00K | 15.70% |
2021-09-30 | $516.00K | 100.00% |
2021-06-30 | - | -100.00% |
2021-03-31 | $12.05M | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | -100.00% |
2019-06-30 | $57.00K | -10.94% |
2019-03-31 | $64.00K | - |
2018-12-31 | $64.00K | - |
2018-09-30 | $64.00K | - |
2018-06-30 | $64.00K | - |
2018-03-31 | $64.00K | - |
2017-12-31 | $64.00K | - |
2017-09-30 | $64.00K | - |
2017-06-30 | $64.00K | - |
2017-03-31 | $64.00K | - |
2016-12-31 | $64.00K | - |
2016-09-30 | $64.00K | - |
2016-06-30 | $64.00K | - |
2016-03-31 | $64.00K | - |
2015-12-31 | $64.00K | - |
2015-09-30 | $64.00K | - |
2015-06-30 | $64.00K | -98.06% |
2015-03-31 | $3.30M | -37.76% |
2014-12-31 | $5.30M | 20.94% |
2014-09-30 | $4.38M | -5.64% |
2014-06-30 | $4.64M | -1.34% |
2014-03-31 | $4.71M | 28.10% |
2013-12-31 | $3.67M | -11.77% |
2013-09-30 | $4.16M | -1.49% |
2013-06-30 | $4.23M | -11.87% |
2013-03-31 | $4.79M | - |
SCYNEXIS Revenue Breakdown
SCYNEXIS Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 19 | Dec 18 |
---|---|---|---|---|---|
Product | $1.04M | $4.99M | $1.11M | - | - |
License and Service | $139.10M | $103.00K | - | - | - |
License And Service | - | - | $12.05M | $100.00K | $300.00K |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Dec 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Dec 18 | Sep 18 | Jun 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
License and Service | $660.00K | $8.11M | $130.99M | - | - | - | - | - | - | - | - | - |
Product | - | $576.00K | $468.00K | $1.42M | $1.56M | $1.32M | $687.00K | $597.00K | $516.00K | - | - | - |
License And Service | - | - | - | - | - | - | - | - | - | $100.00K | $100.00K | $100.00K |
Latest
SCYNEXIS Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Dec 18 | Sep 18 | Jun 18 |
---|---|---|---|---|---|---|---|---|---|
Product | $1.42M | $1.56M | $1.32M | $687.00K | $597.00K | $516.00K | - | - | - |
License and Service | - | - | - | - | - | - | - | - | - |
License And Service | - | - | - | - | - | - | $100.00K | $100.00K | $100.00K |
Latest
SCYNEXIS Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PAHC | Phibro Animal Health | $977.89M | $273.16M |
PCRX | Pacira BioSciences | $674.98M | $168.57M |
ANIP | ANI Pharmaceuticals | $486.82M | $148.33M |
IRWD | Ironwood Pharmaceuticals | $442.74M | $91.59M |
ORGO | Organogenesis | $433.14M | $115.18M |
EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
KMDA | Kamada | $144.76M | $37.40M |
SCYX | SCYNEXIS | $140.14M | $736.00K |
LFCR | Lifecore Biomedical | $128.26M | $24.70M |
ALIM | Alimera Sciences | $80.75M | $23.01M |
CPIX | Cumberland Pharmaceuticals | $39.55M | $9.09M |
TKNO | Alpha Teknova | $36.68M | $9.58M |
BFRI | Biofrontera | $34.01M | $7.83M |
GHSI | Guardion Health Sciences | $12.25M | $36.35K |
SSIC | Silver Spike Investment | $11.72M | $2.76B |
AKAN | Akanda | $2.16M | $762.61K |
LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
SHPH | Shuttle Pharmaceuticals | - | - |